Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinovac: China Vaccine Sales Drop Due to New Government Policies

publication date: May 27, 2016
Sinovac Biotech, a Beijing vaccine company, reported that new government regulations caused China vaccine revenues to fall 50% in Q1. After the recent vaccine distribution scandal in Shandong Province, China's State Council required vaccine makers to participate in the provincial tendering process -- even though their products are sold to the private pay market. Provincial drug councils don't have procedures in place for these new regulations, and sales of vaccines slid lower in Q1 of this year as a result. Sinovac expects Q2 sales will be lower as well. More details....

Stock Symbol: (NYSE: SVA)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital